Kalani M Yashar S, Ramey Wyatt, Albuquerque Felipe C, McDougall Cameron G, Nakaji Peter, Zabramski Joseph M, Spetzler Robert F
Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
Neurosurgery. 2014 May;74(5):482-97; discussion 497-8. doi: 10.1227/NEU.0000000000000312.
Given advances in endovascular technique, the indications for revascularization in aneurysm surgery have declined.
We sought to define indications, outline technical strategies, and evaluate the outcomes of patients treated with bypass in the endovascular era.
We retrospectively reviewed all aneurysms treated between September 2006 and February 2013.
We identified 54 consecutive patients (16 males and 39 females) with 56 aneurysms. Aneurysms were located along the cervical internal carotid artery (ICA) (n = 1), petrous/cavernous ICA (n = 1), cavernous ICA (n = 16), supraclinoid ICA (n = 7), posterior communicating artery (n = 2), anterior cerebral artery (n = 4), middle cerebral artery (MCA) (n = 13), posterior cerebral artery (PCA) (n = 3), posterior inferior cerebellar artery (n = 4), and vertebrobasilar arteries (n = 5). Revascularization was performed with superficial temporal artery (STA) to MCA bypass (n = 25), STA to superior cerebellar artery (SCA) (n = 3), STA to PCA (n = 1), STA-SCA/STA-PCA (n = 1), occipital artery (OA) to PCA (n = 2), external carotid artery/ICA to MCA (n = 15), OA to MCA (n = 1), OA to posterior inferior cerebellar artery (n = 1), and in situ bypasses (n = 8). At a mean clinical follow-up of 18.5 months, 45 patients (81.8%) had a good outcome (Glasgow Outcome Scale 4 or 5). There were 7 cases of mortality (12.7%) and an additional 9 cases of morbidity (15.8%). At a mean angiographic follow-up of 17.8 months, 14 bypasses were occluded. Excluding the 7 cases of mortality, the majority of aneurysms (n = 42) were obliterated. We identified 7 cases of residual aneurysm and recurrence in 6 patients at follow-up.
Given current limitations with existing treatments, cerebral revascularization remains an essential technique for aneurysm surgery.
鉴于血管内技术的进步,动脉瘤手术中血管重建的适应证有所减少。
我们试图明确适应证,概述技术策略,并评估血管内时代接受搭桥治疗患者的结局。
我们回顾性分析了2006年9月至2013年2月期间治疗的所有动脉瘤。
我们确定了54例连续患者(16例男性和39例女性),共56个动脉瘤。动脉瘤位于颈内动脉(ICA)颈部段(n = 1)、岩骨/海绵窦段ICA(n = 1)、海绵窦段ICA(n = 16)、床突上段ICA(n = 7)、后交通动脉(n = 2)、大脑前动脉(n = 4)、大脑中动脉(MCA)(n = 13)、大脑后动脉(PCA)(n = 3)、小脑后下动脉(n = 4)和椎基底动脉(n = 5)。血管重建采用颞浅动脉(STA)至MCA搭桥(n = 25)、STA至小脑上动脉(SCA)(n = 3)、STA至PCA(n = 1)、STA-SCA/STA-PCA(n = 1)、枕动脉(OA)至PCA(n = 2)、颈外动脉/ICA至MCA(n = 15)、OA至MCA(n = 1)、OA至小脑后下动脉(n = 1)以及原位搭桥(n = 8)。平均临床随访18.5个月时,45例患者(81.8%)预后良好(格拉斯哥预后评分量表为4或5)。有7例死亡(12.7%),另有9例出现并发症(15.8%)。平均血管造影随访17.8个月时,14条搭桥血管闭塞。排除7例死亡病例后,大多数动脉瘤(n = 42)闭塞。随访时我们发现7例残留动脉瘤,6例患者出现复发。
鉴于现有治疗方法目前存在的局限性,脑血运重建仍然是动脉瘤手术的一项重要技术。